Dienogest is a synthetic steroid that has been used as a progestogen in contraceptive pills and is currently being studied for its possible clinical use in the treatment of endometriosis. In this study, we investigated the direct effects of dienogest in differentiation and proliferation of human endometrial stromal cells (ESC) in vitro. After 12 days in the presence of oestradiol (10 -8 mol/l) plus dienogest (10 -6 mol/l), cultured ESC underwent morphological differentiation and produced prolactin, a typical marker for decidualization. By using Northern blot analysis and radioimmunoassay, it was shown that treatment of ESC with oestradiol (10 -8 mol/l) plus dienogest (10 -9 to 10 -6 mol/l) led to an increase in the levels of prolactin mRNA and prolactin production in a dose-dependent manner. Additionally, RU-486, a progesterone receptor antagonist, almost completely inhibited dienogest-induced prolactin production. As shown by the thymidine uptake method, there was a dose-dependent inhibition of ESC proliferation with dienogest (P < 0.01, control versus concentrations >10 -7 mol/l). The significant inhibition of ESC proliferation by dienogest (10 -7 mol/l) was partially reversed by RU-486 (10 -6 mol/l). In summary, dienogest directly acts on endometrial tissue in progestogenic response, such as decidualization, increased prolactin production and growth retardation. These data imply that dienogest exerts direct effect in suppressing growth of endometriotic implants.
Introduction
both the 19-nortestosterone derivatives and the progesterone derivatives (Figure 1 ), as well as having unique pharmacoEndometriosis is a complex gynecological disorder, with varied dynamic and pharmacokinetic properties (Kuhl, 1996; Foster and diverse symptomatology, including pelvic pain, dysand Wilde, 1998) . Dienogest was known as STS 557 and has menorrhoea, dyspareunia and infertility. Various drugs have been shown to have high progestational activity according to been employed in the medical treatment of endometriosis an assay by secretory transformation of oestrogen-primed (Lessey, 2000; Minjarez and Schlaff, 2000) . The medications endometrium in immature rabbits (Oettel and Kurischko, 1980) . most commonly used include danazol (17β-hydroxy-2,4, 17α-Dienogest has moderate affinity (~10% of that of progesterone) pregnadien-zo-yno [2,3-d] isoxazole) gonadotrophin-releasing for the progesterone receptor in human uterine tissue in vitro, hormone (GnRH) agonists and progestins. Although these (Kaufmann et al., 1983; Oettel et al., 1993; Kuhl, 1996) . agents are relatively effective against endometriosis, they However, the binding affinities of dienogest to the androgen produce a high incidence of adverse reactions. Due to its receptor are low and there is no or nearly no affinity to the anabolic/androgenic activity, danazol leads to side-effects oestrogen, aldosterone or glucocorticoid receptors (Oettel et al., including abnormal lipid metabolism, liver dysfunction, and 1993; Kuhl, 1996) . Although slight oestrogenic effects of cerebral thrombosis (Barbieri, 1990; Kauppila, 1993) . Progestin dienogest have been detected in animal models (Koch, 1984) , causes weight gain, lethargy, depression, and thrombosis these did not occur with clinically relevant doses in women (Moghissi, 1988; Metzger and Luciano, 1989), whereas GnRH (Foster and Wilde, 1998) . This peculiarity appears to be agonists cause profound hypo-oestrogenaemia associated with responsible for the fact that dienogest has no androgenic hot flushes and reductions in bone mineral density (Judd, 1992;  properties and even some antiandrogenic properties (Kuhl, Adashi, 1994) . Thus, new agents with a higher efficacy and 1996; Katsuki et al., 1997a; Foster and Wilde, 1998) . This fewer side-effects would be highly desirable.
compound was initially assessed for its contraceptive value, Dienogest (17α-cyanomethyl-17β-hydroxy-estra-4, 9-dien-3-one), is a synthetic steroid that combines properties of and it is now available in combination with ethinyl oestradiol becco's modified Eagle's medium (DMEM)/Ham's F-12 medium (Gibco BRL, Grand Island, NY, USA) and minced into small pieces of Ͻ1 mm 3 . The tissues were then incubated for 2 h at 37°C in DMEM/F-12 medium containing 1 mg/ml collagenase (Wako Pure Chemical Co. Ltd, Osaka, Japan) and 0.005% deoxyribonuclease (DNase) type I (Boehringer Mannheim GmbH, Mannheim, Germany). After subsequent pipetting, the cell suspension was diluted with 2-volume DMEM/F-12 medium and placed in a centrifugation tube (Corning Glass Works, Corning, NY, USA), where it remained upright for 10 min at unit gravity. The supernatant, excluding the lowermost 2 ml, was transferred into a new tube to collect suspended single cells. After repeating this procedure several times, the cell suspension was washed three times and used as a source of ESC. The viability, Figure 1 . Structural formulae of dienogest, progesterone, oestradiol, determined by dye exclusion, was ജ90%. Two million viable ESC testosterone, and cortisone.
were cultured in 75 cm 2 flasks in DMEM/F-12 medium supplemented with 10% fetal calf serum (FCS; HyClone, Logan, UT, USA),
in Germany as a low-dose pill. With this hormonal profile, 100 IU/ml penicillin, and 100 µg/ml streptomycin (Gibco BRL) at dienogest appears to cause few side-effects in its clinical use 37°C in humidified atmosphere of 5% CO 2 in air. The culture (Kuhl, 1996; Foster and Wilde, 1998) . In female rats and medium was replaced 30 min after plating to reduce epithelial cell female monkeys, dienogest showed no effect on the bleeding contamination. The purity of ESC was determined by morphology and by immunohistochemical staining as described previously (Inoue time, coagulation, fibrinolysis and platelet aggregation, in et al., 1996) with markers specific to ESC (vimentin), epithelial contrast with medroxyprogesterone acetate and danazol glands (cytokeratin), endothelial cells (factor VIII), or leukocytes (Katsuki et al., 1998a; Nobukata et al., 1999) . Recent studies showing an objective endoscopic and subjective symptomatic improvement in 80 and 83% respectively (Köhler et al., 1987, Steroid hormone treatment 1989). Currently, it is being investigated in Germany, France
To remove the effect of endogenous steroid hormones, FCS to be and Japan as an agent for the treatment of endometriosis.
used in the cell culture was treated as follows. One hundred ml FCS mixed with 0.25 g activated charcoal (Sigma Chemical Co., St Louis, However, the direct effects of dienogest on human endo-and interleukin-15 (Schatz and Lockwood, 1993; Hatayama et al., 1994; Higuchi et al., 1995;  Zhang and Salamonsen,
RNA extraction and Northern blotting
1997; Krikun et al., 1998; Okada et al., 2000) . In this study, Total RNA was prepared from cultured cells by the acid guanidiniumwe investigated the direct effects of dienogest on proliferation phenol-chloroform method using TRIzol Reagent (Gibco BRL). Total and differentiation of ESC cultured in vitro.
RNA (20 µg) was separated in a 1.2% formaldehyde gel and transferred to Hybond-N ϩ nylon membrane (Amersham Corp., Arlington Heights, IL, USA). The probe was labelled by the multi-
Materials and methods
prime DNA labelling system (Amersham). Human prolactin probe Isolation and culture of ESC (Okada et al., 1999) and human S26 probe (Okada et al., 2000) , which recognizes the mRNA-binding human ribosomal protein RNA, ESC were purified from the proliferative phase endometrium and cultured as described previously (Hatayama et al., 1994; Okada were prepared as described previously. Hybridization was done at 42°C for 18 h in 5ϫstandard saline-phosphate-EDTA (SSPE) / et al., 1999, 2000) . Briefly, tissue samples were washed with Dul-5ϫDenhardt's solution/50% formamide/0.5% sodium dodecyl sulphate (SDS)/100 µg/ml salmon sperm DNA. The filters were washed at room temperature in 2ϫstandard saline citrate (SSC)/ 0.1% SDS, following by 0.1ϫSSC/0.1% SDS at 50°C, and then autoradiographed. The membranes were deprobed and rehybridized with the human S26 probe as an internal control, because its expression level is virtually constant in many tissues (Vincent et al., 1993) . The mRNA levels were calculated after normalization to S26 mRNA expression on the basis of the hybridized signal as measured in a BAS 2000 Bioimage Analyzer (Fujix, Tokyo, Japan). Each value indicates the mean Ϯ SD for four cultures obtained from four patients.
Prolactin assay by radioimmunoassay
The prolactin concentration in the culture medium was measured by radioimmunoassay using a commercial kit (Daiichi Radioisotope Lab., Tokyo, Japan). The detection limit was 1.0 ng/ml. Prolactin values were standardized on the basis of the number of cells counted at the time when the culture media were collected for the prolactin assay. Studies were performed with five cultures obtained from five patients, each in triplicate wells.
Cell proliferation assay ESC proliferation was measured by a [methyl-3 H]thymidine incorporation assay. ESC were cultured for 2-4 days until subconfluence in 75 cm 2 flasks and were subsequently cultured to 6-well plates. ESC (5ϫ10 4 cells) in 6-well plates were made quiescent by incubation in the presence of Phenol Red-free DMEM/F-12 supplemented with 0.1% DCS-FCS. After 48 h of serum starvation, the medium was removed and replaced with control medium of Phenol Red-free DMEM/F-12 supplemented with 1% DCS-FCS containing the control vehicle or steroids. After 20 h of incubation, [methyl-3 H]thymidine (1 µCi/well) (Amersham) was added 4 h before harvest. ESC were washed three times with ice-cold PBS (phosphatebuffered saline). After the addition of ice-cold 10% TCA (tri- Figure 2 . In-vitro decidualization of human endometrial stromal chloroacetic acid) for 10 min on ice, ESC were washed three times cells (ESC) induced by oestradiol and dienogest. (A) After 12 days with ice-cold 5% TCA. The acid-insoluble fractions were dissolved of oestradiol 10 -8 mol/l treatment, ESC retained a spindle-shaped in 0.5 N NaOH for 10 min on ice, and then HCl and TCA were appearance. (B) After 12 days of oestradiol (10 -8 mol/l) plus added to a final concentration of 0.5 N and 10% respectively. Cell dienogest (10 -6 mol/l) treatment, ESC were transformed into lysates filtrated through the GF/C filters (Whatman, Maidstone, UK) polygonal cells resembling decidual cells in vivo. Original and the filters were washed three times with ethanol. The GF/C magnification ϫ150. filters were transferred to scintillation vials and the incorporation of We evaluated whether oestradiol plus dienogest regulated the expression of prolactin mRNA using the cultured ESC. in the presence of oestradiol (10 -8 mol/l) alone. In contrast, using analysis of variance with repeated measurements, followed by oestradiol (10 -8 mol/l) plus progesterone (10 -6 mol/l) or oestraFisher's protected least significant difference, multiple range test. A level of P Ͻ 0.05 was considered statistically significant. diol (10 -8 mol/l) plus dienogest (10 -6 mol/l) caused a significant and similar increase in prolactin mRNA (Figure 3) . The prolactin concentrations in the culture medium as measured
Results
by radioimmunoassay also showed the same results as the mRNA experiments (Figure 4) . Treatment of ESC with Decidualization of ESC was determined by morphology and prolactin production. Morphological studies showed that ESC dienogest (10 -9 to 10 -6 mol/l) led to an increase in the levels of prolactin mRNA and prolactin production in a dosecultured with oestradiol remained fibroblastic in appearance throughout the culture period (Figure 2A) . In contrast, after dependent manner (Figures 3 and 4) . Additionally, RU-486, an antiprogestin compound that exerts a high affinity for the progesterone receptor, almost completely inhibited the 10 -7 mol/l in the culture medium had no inhibitory effect endometriosis tissues Misao et al., 1999) . However, the present study using eutopic endometrial cells should help to understand the mechanism of the effect of dienogest in endometriosis treatment. The question that we asked was whether dienogest might directly inhibit growth and proliferation of ESC. Our data clearly demonstrate a direct inhibition of proliferation of ESC by dienogest as assessed by the thymidine uptake method. ESC were growth-arrested by serum starvation and subsequently cultured in the condition medium. We have previously shown that the cultured ESC expressed nuclear receptors for the steroid hormones progesterone, androgen and oestrogen (Iwai et al., 1995) . This model allowed us to investigate the mitogenic effects of steroid hormones. Indeed, the investigations have attempted to demonstrate the direct effects of danazol, progestin and GnRH agonists on proliferation of ESC in vitro (Rose et al., 1988; Surrey and Halme, 1992) . The addition of dienogest in the culture medium inhibited the growth of ESC in a concentration-dependent manner and this inhibition adequacy of the present experiments is supported by reports supplemented with 0.1% dextran-coated charcoal-stripped fetal calf serum for 48 h and then were incubated for 24 h in control medium that danazol (10 -5 mol/l) had a direct inhibitory effect on the containing the following agents: dimethylsulphoxide as vehicle growth of ESC in culture (Rose et al., 1988) . ESC proliferation (Bhargava-Periwal et al., 1996) , although the experimental conditions were not clearly stated. Other on the [ 3 H]thymidine incorporation by ESC, but the higher investigations have demonstrated that progesterone stimuconcentration of danazol (10 -5 mol/l) significantly suppressed lates the proliferation of cultured ESC to a greater degree proliferation ( Figure 6 ). Progesterone at concentrations than cells grown in control medium alone, as indicated by Ͼ10 -7 mol/l also significantly inhibited the growth of ESC measurement of cell number after 9-15 days culture (Irwin in a dose-dependent manner (data not shown).
et al., 1989, 1991) . However, the possibility exists that the stimulatory effects of progesterone depend on some growth Discussion factors produced with decidualization of ESC after 9-15 days of treatment with progesterone. Indeed, progestin is suggested In this study, the possible direct effect of dienogest on differentiation and proliferation on ESC was examined in vitro.
to regulate an autocrine growth control loop in the endometrium that involves IGF, IGF receptor and IGFBP (Frost et al., 1993) . ESC can be decidualized in vitro with progesterone. This in-vitro model has provided an opportunity to investigate
The phamacokinetics of a single oral dose of dienogest had been assessed in female volunteers (Foster and Wilde, 1998) . production and regulation of prolactin, which was produced by ESC with progesterone or dienogest. The binding affinities Maximum serum dienogest concentrations were reached within~2 h and the mean maximum serum concentrations of dienogest for human, rat and rabbit progesterone receptors have been reported to be as low as 10, 11 and 17%, respectively, were 0.9ϫ10 -7 , 1.7ϫ10 -7 , 3.2ϫ10 -7 , 6.8ϫ10 -7 mol/l after 1, 2, 4, 8 mg therapeutic doses respectively (Foster and Wilde, of that of progesterone (Kaufmann et al., 1983; Oettel et al., 1993; Kuhl, 1996; Katsuki et al., 1997a) . However, we found 1998). Since dienogest (10 -7 mol/l) had a significant inhibitory effect on the [ 3 H]thymidine incorporation by ESC, dienogest that ESC cultured in the presence of dienogest underwent apparent morphological differentiation and produced prolactin, may directly inhibit the proliferation of ESC at therapeutic doses. In view of the role of dienogest in the growth characa typical marker for decidualization. This action of dienogest on cultured ESC was similar to that of progesterone. Furtherteristics of ESC, the study on the effect of metabolites of dienogest may be important. However, the metabolites of more, RU-486 as a progesterone receptor antagonist almost completely inhibited dienogest-induced prolactin production. dienogest generally show less affinity for the progesterone receptor compared with the parent compound (Oettel et al., Our results indicate that the effect of dienogest might be mediated via the progesterone receptor of ESC. The effects 1993). Dienogest is also suggested to be an antagonist of angioof dienogest on endometrium may differ from those for endometriosis tissues, because there exist some differences in genesis and its antiangiogenic action may be involved in its therapeutic effects on endometriosis. Angiogenesis is essential the expression of steroid receptors between endometrial and
